A share price of Apogee Therapeutics Inc [APGE] is currently trading at $80.75, down -2.04%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The APGE shares have gain 4.22% over the last week, with a monthly amount glided 5.13%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stephens started tracking the stock with Overweight rating on December 17, 2025, and set its price target to $95. On December 10, 2025, Deutsche Bank initiated with a Buy rating and assigned a price target of $103 on the stock. Craig Hallum started tracking the stock assigning a Buy rating and suggested a price target of $109 on November 03, 2025. Mizuho initiated its recommendation with a Outperform and recommended $105 as its price target on October 21, 2025. RBC Capital Mkts started tracking with a Outperform rating for this stock on September 25, 2025, and assigned it a price target of $60. In a note dated July 07, 2025, BTIG Research reiterated an Buy rating on this stock and boosted its target price from $100 to $115.
Apogee Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $26.20 and $84.56. Currently, Wall Street analysts expect the stock to reach $107.33 within the next 12 months. Apogee Therapeutics Inc [NASDAQ: APGE] shares were valued at $80.75 at the most recent close of the market. An investor can expect a potential return of 32.92% based on the average APGE price forecast.
Analyzing the APGE fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.39 and Total Capital is -0.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Apogee Therapeutics Inc [NASDAQ:APGE] is 15.86. Further, the Quick Ratio stands at 15.86, while the Cash Ratio is 3.17.
Transactions by insiders
Recent insider trading involved Dambkowski Carl, Chief Medical Officer, that happened on Jan 07 ’26 when 18700.0 shares were sold. Officer, CARL DAMBKOWSKI completed a deal on Jan 07 ’26 to buy 35200.0 shares. Meanwhile, Chief Financial Officer Henderson Jane sold 6000.0 shares on Jan 02 ’26.
